GGrantIndex
Sort

64,565 grants matching drug discovery

Discovery And Functional Genomics Of Environmental Response Genes

$1,884,786
Douglas Bell · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES

NORMAL & NEOPLASTIC GROWTH IN THE BRAIN

$1,884,764
Suzanne J Baker · St. Jude Children'S Research Hospital · P01 · FY2021 · CA

Therapies for patients with rare tumors and genetic tumor predisposition

$1,884,219
Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA

Cell Identity and Signaling (CIS)

$1,884,000
Ourania M. Andrisani · Purdue University · P30 · FY2025 · CA

Cancer Center Support Grant

$1,884,000
Andrew D Mesecar · Purdue University · P30 · FY2025 · CA

Alzheimer's Disease Core Center

$1,883,508
Thomas M Wisniewski · New York University School Of Medicine · P30 · FY2015 · AG

Biology and Novel Therapeutics of Cardiovascular Peptides

$1,882,473
John C Burnett · Mayo Clinic Rochester · P01 · FY2015 · HL

Development of LPA5 Antagonists as Analgesics

$1,881,741
Yanan Zhang · Research Triangle Institute · R61 · FY2023 · NS

CCR Office of Training and Education

$1,881,720
Jonathan Scott Wiest · Division Of Basic Sciences - Nci · ZIJ · FY2017 · CA

SPORE in Myeloid Malignancies

$1,881,692
Benjamin Levine Ebert · Dana-Farber Cancer Inst · P50 · FY2020 · CA

SPORE in Prostate Cancer

$1,881,489
Samuel R Denmeade · Johns Hopkins University · P50 · FY2018 · CA

Alzheimer's Disease Core Center

$1,881,451
Thomas M Wisniewski · New York University School Of Medicine · P30 · FY2019 · AG

Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease

$1,881,158
Clinton H. Joiner · Emory University · U01 · FY2015 · HL

SPORE in Prostate Cancer

$1,881,134
Sarki A. Abdulkadir · Northwestern University At Chicago · P50 · FY2025 · CA

Vanderbilt NCDDDG for Discovery of Novel Treatments for Schizophrenia

$1,880,515
P Jeffrey Conn · Vanderbilt University · U01 · FY2012 · MH

Vanderbilt NCDDDG for Discovery of Novel Treatments for Schizophrenia

$1,880,513
P Jeffrey Conn · Vanderbilt University · U01 · FY2014 · MH

Interdisciplinary center of excellence for the study of pain and sensory function

$1,880,487
Ian D Meng · University Of New England · P20 · FY2015 · GM

African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation

$1,880,357
Minoli A Perera · Northwestern University At Chicago · U54 · FY2017 · MD

Development & Utilization of a Novel Aerosol-Generating Technology to Deliver Luc

$1,880,292
Robert Segal · Discovery Laboratories, Inc. · R44 · FY2014 · HL

Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda

$1,879,403
Matthew G Dorsey · University Of California, San Francisco · U19 · FY2016 · AI

Use of systems pharmacology to prevent rod and cone photoreceptor degeneration

$1,878,337
Krzysztof Palczewski · Case Western Reserve University · R24 · FY2017 · EY

UCSC-Buck Inst. Genome Data Analysis Center for TCGA Research Network (GDAC)

$1,877,957
David H Haussler · University Of California Santa Cruz · U24 · FY2013 · CA

Transdisciplinary Program to Identify Novel Antifungal Targets and Inhibitors

$1,877,844
John R. Perfect · Duke University · P01 · FY2015 · AI

SPORE in Prostate Cancer

$1,877,328
William George Nelson · Johns Hopkins University · P50 · FY2014 · CA

Measuring, Modeling and Controlling Heterogeneity

$1,876,979
Joe W. Gray · Oregon Health & Science University · U54 · FY2017 · CA